Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Kyowa Kirin Limited, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom
Pro-Banthine tablets 15 mg.
| Pharmaceutical Form |
|---|
|
Tablets. |
Propantheline Bromide 15 mg.
Excipients with known effect: This medicinal product contains lactose (31 mg) and sucrose (26.74 mg), see section 4.4 for further details.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Propantheline |
Propantheline inhibits parasympathetic activity by blocking the action of the neurohormone, acetylcholine, on the neuroeffector cell. This blocking action of propantheline is instrumental in reducing gastric acid secretion and gastrointestinal motor activity. |
| List of Excipients |
|---|
|
In the tablet core: lactose monohydrate, talc, maize starch, magnesium stearate and light liquid paraffin. In the coating: sucrose, calcium carbonate, saccharin sodium, titanium dioxide (E171), magnesium carbonate light, castor oil virgin, talc, ferric oxide red (E172), ferric oxide yellow (E172), and carnauba wax. |
Foil/PVC-PVdC strips of 100 or 112 tablets.
HDPE bottles of the appropriate size to accommodate 1000 or 5000 tablets.
Not all pack sizes may be marketed.
Kyowa Kirin Limited, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom
PL 16508/0050
28 February 1998
| Drug | Countries | |
|---|---|---|
| PRO-BANTHINE | Australia, Japan, New Zealand, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
